We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Explainer: What Is Diabetic Kidney Disease?
The leading cause of kidney disease in the United States is diabetes, according to the U.S. National Institutes of Health.
From Idea to Reality in a Pilot Plant
CSL Behring uses “pilot plants” to test new manufacturing processes on a small scale in search of big breakthroughs.
Investigating Gene Therapy for Hemophilia B
Here are 5 things to know about this potential therapy.
Using AI and Data Science
With artificial intelligence, “we can get there faster, evaluate faster and relaunch faster when needed.”
Doctoral Candidate Wins Our Innovation Challenge
Australian scientist Stefanie Buchholz presented her work in isolating immunoglobulins and other plasma-derived proteins.
The Promise of Big Data for Lung Disease Patients
The launch of an open-source repository of thousands of lung scans invites a new era of AI-assisted research into rare diseas…
Video: Innovation in Marburg, Germany
CSL Behring’s largest R&D and manufacturing site is in this university town, where game-changing science is happening.
5 Reasons Why Diversity Matters in Clinical Trials
Broadening access to clinical trials is better for science and patients.
Research Aimed at the Sickest COVID-19 Patients
Dr. William Zhang receives the American Thoracic Society/CSL Behring Research Award to study Acute Respiratory Distress Syndr…
Together, Let's Move at the Speed of Science
A condensed version of my address to academia, governments and industry during the Times Higher Education Health and Wellbein…
Listen: The Safety of Vaccines
Gregg Sylvester, Chief Medical Officer and Head of Medical Affairs for Seqirus, discusses vaccine safety on new episode of Wo…
Biotech Firms Respond to IP Debate
Hundreds of CEOs sign a joint statement, saying IP “created the biotech network that responded so quickly to the COVID crisis…
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
